Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival

Ion Mărunţelu; Claudiu Eduard Nistor; Bogdan Mihai Cristea; Corina Andreea Rotarescu; Andreea Mirela Caragea; Maria Tizu; Ileana Constantinescu

doi:10.12659/AOT.937267

12 August 2022 : Original article

Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival

Ion Mărunţelu^12ABCDEF, Claudiu Eduard Nistor

^2CEF*, Bogdan Mihai Cristea^2CE, Corina Andreea Rotarescu^12BCD, Andreea Mirela Caragea^2B, Maria Tizu^2B, Ileana Constantinescu^12AD

DOI: 10.12659/AOT.937267

Ann Transplant 2022; 27:e937267

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Area under curve (AUC). Because P value is less than 0.05, the area under the receiver operating characteristic (ROC) curve is substantially different from 0.5, implying that the laboratory test has the capacity to identify patients at risk to develop human leucocyte antigen (HLA) antibodies.

Back to the Article

Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival

Your Privacy